Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxim Ivanov

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|February 20, 2025
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive diseaseDaria Kravchuk, Alexandra Lebedeva, Olesya Kuznetsova, et al.
Heliyon|May 6, 2024
Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experienceAlexandra Lebedeva, Olesya Kuznetsova, Maxim Ivanov, et al.
JCO Precision Oncology|December 10, 2025
Neoadjuvant Immunotherapy With Prolgolimab in Patients With Locally Advanced Microsatellite Instability/Defective Mismatch Repair Colorectal CancerOlesya Kuznetsova, Albina Zagidullina, Natalia Drobot, et al.
Scientific Reports|October 8, 2024
Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatmentEgor Veselovsky, Alexandra Lebedeva, Olesya Kuznetsova, et al.
International Journal of Molecular Sciences|July 24, 2021
In Vitro and In Vivo Characterization of PLLA-316L Stainless Steel Electromechanical Devices for Bone Tissue Engineering-A Preliminary StudyMariana V Branquinho, Sheila O Ferreira, Rui D Alvites, et al.
International Journal of Molecular Sciences|April 17, 2025
The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy ResponseAlexandra Lebedeva, Anastasiia Taraskina, Tatiana Grigoreva, et al.
Molecular Diagnosis & Therapy|October 5, 2024
Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of DiscordanceAlexandra Lebedeva, Ekaterina Belova, Alexandra Kavun, et al.
World Journal of Oncology|July 12, 2024
Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation TestingAlexandra Lebedeva, Egor Veselovsky, Alexandra Kavun, et al.
Journal of Clinical Laboratory Analysis|March 8, 2025
Analytical and Clinical Validation of Solo-Test Driver: A Targeted Amplicon-Based NGS Test-System for FFPE and cfDNA Analysis in Clinical Oncology SettingMaxim Ivanov, Alexandra Lebedeva, Ekaterina Belova, et al.
BMC Genomics|October 6, 2014
Genetic and epigenetic regulation of gene expression in fetal and adult human liversMarc Jan Bonder, Silva Kasela, Mart Kals, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|February 20, 2025
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive diseaseDaria Kravchuk, Alexandra Lebedeva, Olesya Kuznetsova, et al.
Heliyon|May 6, 2024
Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experienceAlexandra Lebedeva, Olesya Kuznetsova, Maxim Ivanov, et al.
JCO Precision Oncology|December 10, 2025
Neoadjuvant Immunotherapy With Prolgolimab in Patients With Locally Advanced Microsatellite Instability/Defective Mismatch Repair Colorectal CancerOlesya Kuznetsova, Albina Zagidullina, Natalia Drobot, et al.
Scientific Reports|October 8, 2024
Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatmentEgor Veselovsky, Alexandra Lebedeva, Olesya Kuznetsova, et al.
International Journal of Molecular Sciences|July 24, 2021
In Vitro and In Vivo Characterization of PLLA-316L Stainless Steel Electromechanical Devices for Bone Tissue Engineering-A Preliminary StudyMariana V Branquinho, Sheila O Ferreira, Rui D Alvites, et al.
International Journal of Molecular Sciences|April 17, 2025
The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy ResponseAlexandra Lebedeva, Anastasiia Taraskina, Tatiana Grigoreva, et al.
Molecular Diagnosis & Therapy|October 5, 2024
Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of DiscordanceAlexandra Lebedeva, Ekaterina Belova, Alexandra Kavun, et al.
World Journal of Oncology|July 12, 2024
Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation TestingAlexandra Lebedeva, Egor Veselovsky, Alexandra Kavun, et al.
Journal of Clinical Laboratory Analysis|March 8, 2025
Analytical and Clinical Validation of Solo-Test Driver: A Targeted Amplicon-Based NGS Test-System for FFPE and cfDNA Analysis in Clinical Oncology SettingMaxim Ivanov, Alexandra Lebedeva, Ekaterina Belova, et al.
BMC Genomics|October 6, 2014
Genetic and epigenetic regulation of gene expression in fetal and adult human liversMarc Jan Bonder, Silva Kasela, Mart Kals, et al.
Pageof 7